Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
5,659
Ticker
1801
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Disclosures of Innovent Biologics

Explore Innovent Biologics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Innovent Biologics's official channels and fully traceable to its official company sources.

The table below lists all of Innovent Biologics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Annual Report2024
ESG Report2024
Annual Report2023
ESG Report2023
Annual Report2022
ESG Report2022
ESG Report2021
Annual Report2021
Financial & Extra-Financial Disclosure2021
Financial & Extra-Financial Disclosure2020
ESG Report2020
Annual Report2020
ESG Report2019
Financial & Extra-Financial Disclosure2019
Annual Report2019
Annual Report2018
Financial & Extra-Financial Disclosure2018
ESG Report2018
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?